Figure 3: Kaplan-Meier Survival Curves for the Primary Composite Outcome in Patients Treated With Placebo Versus Varespladib (VISTA-16, Phase 3)

2019-06-11T07:04:27Z (GMT) by Jennifer A. Rymer L. Kristin Newby
VISTA-16 = Vascular Inflammation Suppression to Treat Acute Coronary Syndrome for 16 weeks; other abbreviations as in Figure 2.

Categories

License

Elsevier user license